US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist

3.630
+0.150+4.31%

Close Nov 27 16:00 ET

3.630
0.0000.00%

Post 20:01 ET

258.69MMarket Cap-1452P/E (TTM)

Zentalis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zentalis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	40.560M / 11.667M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q140.560M / 11.667M--

Unlock Free Earnings Estimates

Open Account

Zentalis Pharmaceuticals Earnings Reports

Zentalis Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:05 ET

Zentalis Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 9 07:07 ET

Zentalis Pharmaceuticals | 8-K: Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress

Aug 9 07:02 ET

Zentalis Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 7 07:09 ET

Analyst Rating

Updated: Nov 15, 2024

Buy

Buy
57.14%
Hold
42.86%
Sell
0.00%

Price Target

No Data

Heat List

Overall